Both BTN and BTNL molecules have a broad expression profile, with demonstrated surface expression on various immune cell subsets (Table 1) [18], as well as epithelial tissues such as the gut and some cancers; these include breast and ovarian carcinomas [17,19]. Here, BTN1A1 is linked to ovarian carcinoma.